Contraception
Volume 80, Issue 6 , Pages 527-532 , December 2009

Continuation rates and reasons for removal among Implanon® users accessing two family planning clinics in Queensland, Australia

  • Caroline Harvey

      Affiliations

    • Family Planning Queensland, Queensland 4006, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 7 3250 0219.
    • ,
  • Charrlotte Seib

      Affiliations

    • School of Nursing, Queensland University of Technology, Queensland 4059, Australia
    • ,
  • Jayne Lucke

      Affiliations

    • School of Population Health, The University of Queensland, Queensland 4072, Australia

Received 1 May 2009 ,Accepted 27 May 2009.

References 

  1. Weisberg E, Fraser I. Australian women's experience with Implanon. Aust Fam Physician. 2005;34:694–696
  2. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception. 1998;58(6 Suppl):99S–107S
  3. Croxatto HB, Urbancsek J, Massai R, Coelingh Bennink H, van Beek A. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. Hum Reprod. 1999;14:976–981
  4. Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care. 2008;13(Suppl 1):13–28
  5. Halpern V, Grimes DA, Lopez L, Gallo MF. Strategies to improve adherence and acceptability of hormonal methods for contraception. Cochrane Database Syst Rev. 2006;CD004317
  6. Hubacher D, Goco N, Gonzalez B, Taylor D. Factors affecting continuation rates of DMPA. Contraception. 1999;60:345–351
  7. Belsey EM, Task Force on Long-Acting Systemic Agents for Fertility Regulation . The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception. 1988;38:207–225
  8. Tolley E, Loza S, Kafafi L, Cummings S. The impact of menstrual side effects on contraceptive discontinuation: findings from a longitudinal study in Cairo, Egypt. Int Fam Plan Perspect. 2005;31:15–23
  9. Lei ZW, Wu SC, Garceau RJ, et al. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception. Contraception. 1996;53:357–361
  10. Agrawal A, Robinson C. An assessment of the first 3 years' use of Implanon in Luton. J Fam Plann Reprod Health Care. 2005;31:310–312
  11. Lakha F, Glasier AF. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception. 2006;74:287–289
  12. Rai K, Gupta S, Cotter S. Experience with Implanon in a northeast London family planning clinic. Eur J Contracept Reprod Health Care. 2004;9:39–46
  13. Smith A, Reuter S. An assessment of the use of Implanon in three community services. J Fam Plann Reprod Health Care. 2002;28:193–196
  14. National Health and Medical Research Council . When does quality assurance in health care require independent ethical review?. Canberra: Commonwealth of Australia; 2003;Available from: http://www.nhmrc.gov.au/publications/synopses/e46syn.htm
  15. National Collaborating Centre for Women's and Children's Health. Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception. London: RCOG Press; 2005;Commissioned by the National Institute for Health and Clinical Excellence. Available from: http://www.nice.org.uk/CG030
  16. Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995;85:795–800
  17. Fleming D, Davie J, Glasier A. Continuation rates of long-acting methods of contraception. Contraception. 1998;57:19–21

☆ This clinical audit was funded by Organon (now Schering Plough) and Family Planning Queensland. Organon was not involved in the interpretation or reporting of the findings of the study. FPQ has received honoraria from Organon for contraception training sessions and Advisory Board attendance provided by Caroline Harvey. Organon provided travel support to Caroline Harvey for attendance at international contraception conferences. Charrlotte Seib and Jayne Lucke hold honorary positions as directors on the Board of Family Planning Queensland.

PII: S0010-7824(09)00300-X

doi: 10.1016/j.contraception.2009.05.132

Contraception
Volume 80, Issue 6 , Pages 527-532 , December 2009

Article Tools

* Image Usage & Resolution